ABSTRACT Background With
The principal aims of long-term oxygen therapy are to prevent harm from chronic hypoxaemia and to improve any related symptoms. 1 Home oxygen is used either to allow patients to be discharged safely from hospital or to improve symptoms or quality of life in children in the community with chronic hypoxaemia. An evidence-based guideline for home oxygen use in children has recently been published. 2 A new national home oxygen service for England and Wales was introduced in February 2006, which awarded four companies contracts to provide all the necessary equipment for 11 oxygen regions. 3 4 Ordering was done using a standard Home Oxygen Order Form (HOOF), available from the Department of Health and on the British Paediatric Respiratory Society website (http:// www.bprs.co.uk/oxygen.html). Home oxygen is an expensive therapeutic intervention, but during Use of home oxygen for children in England and Wales R A Primhak, 1 B Hicks, 2 N J Shaw, 3 G C Donaldson, 4 I M Balfour-Lynn 2 the setting up of this service, it became clear that little was known about numbers of children receiving home oxygen or their clinical diagnoses. There was also no system in place to monitor its clinical use. The Children's Home Oxygen Record Database (CHORD) was set up with the aim of assessing the incidence and patterns of home oxygen prescription. In addition, a single time point survey was carried out, with data obtained from all the oxygen provider companies to the British Thoracic Society (BTS) Home Oxygen Database Committee, and the paediatric data have been analysed.
METHODS

Prospective CHORD study
A paediatric home oxygen clinical network was established with a lead clinician identifi ed in each of the 11 regions. Prescribers were requested to obtain consent from parents/carers and to send a copy of the HOOF in to CHORD, for all new prescriptions made in the 3- prevalence for home oxygen use among children <16 years in England and Wales was 0.33 per 1000 population, with a peak of 1.08 per 1000 for those <1 year (fi g 2). Regional data are shown in fi g 3 (plus table in online supplement), with prevalence ranging from 0.47 per 1000 in the North East to 0.25 per 1000 in Yorkshire. Only 574 (17%) children had a diagnostic code entered by the prescriber or recorded by the oxygen companies, and of these, 181 were coded as 20 ("other"). One company automatically recorded code 20 if no diagnostic code was given. Thus, only 393 (11%) had a meaningful diagnostic code entered (table 1) .
DISCUSSION
We have, for the fi rst time, collected national data for England and Wales on the use of home oxygen in children. During the planning of the new centralised home oxygen service, it emerged that healthcare commissioners did not have data on how many children (or adults either) were receiving home oxygen at the time. Undoubtedly, individual companies had their own data but these were not available because of commercial sensitivities during the tendering process; hence, there was no national data. There is in fact very little information published in any country, although there is a Danish Oxygen Register the regional oxygen leads would ensure other hospital specialists in their region were aware of the database. It was assumed that with the new centralised system, prescribers of paediatric home oxygen would be hospital paediatricians rather than general practitioners (GPs). Data were entered on to a Microsoft Access database. Missing diagnostic codes were obtained from hospital prescribers or GPs. Ethical approval was obtained (Central Offi ce for Research Ethics Committees (COREC) reference 05/Q1407/190).
Providers cross-sectional survey
After an agreement with the BTS Home Oxygen Working Group, anonymised data recorded from the HOOFs for children and adults in possession of home oxygen on a single day in June 2007 were obtained from all four home oxygen providers in England and Wales. We were unable to validate ascertainment rates, but it was likely to be almost complete. Duplicate data were eliminated, and records on the same patient were combined if the same person was prescribed oxygen for more than one location. We analysed the data for patients aged <16 years only. Diagnostic codes 11 (chronic heart failure) and 15 (paediatric cardiac disease) were combined as cardiac disease, and codes for interstitial lung disease (5) and paediatric interstitial lung disease (12) were also combined. Midyear residential population estimates were obtained for England and Wales for 2007 from the Offi ce of National Statistics (http://www.statistics.gov.uk), and prevalence rates were calculated against the age-matched population. Children's postcodes were matched to strategic health authorities to obtain regional data. Ethical approval was obtained (COREC reference 06/Q0501/21).
RESULTS
Data on oxygen-prescribing patterns including oxygen fl ows and duration are provided as an online supplement [ADC to enter weblink].
Prospective CHORD study
A total of 905 forms were received during the 3-year period. In addition, we received 66 anonymised refusal notifi cations. We also received data on 255 children that we could not use-127 HOOFs without consent and 128 untraceable consent forms without HOOFs. In 17 forms, the age at prescription was >16 years, and these were excluded from analysis, leaving 888 children prescribed home oxygen. These included 310 with incomplete data, which ranged from GP name to incomplete oxygen-prescribing data. The median age of the patients at the time of prescribing was 0.34 years (4.1 months), with 656 (74%) <1 year; 58% were male. Due to signifi cant under-reporting, a national incidence rate and regional variations cannot be calculated. Diagnostic codes were eventually available for 98% children, with more than 90% having an identifi able condition, that is, not code 20 "other" (table 1) .
Providers cross sectional survey
In total, there were 91 727 records received, and after cleaning-up of data, this meant there were 86 630 patients on domiciliary oxygen in England and Wales during June 2007. There were 3338 (4%) paediatric patients aged ≤15 years and 83 292 (96%) adult patients aged ≥16 years. The median age of the children was 3.1 years (range 29 days to 15 years and 364 days), and the age distribution is shown in fi g 1. The overall point No other diagnostic code occurred in more than 3% of the children in CHORD and no more than 5% in the cross-sectional survey. The difference in diagnostic categories between the two databases was signifi cant (p<0.0001), using a χ 2 test. with a publication that indicated that 23 (10.5%) of 2190 patients on home oxygen were <18 years old (this compares with our fi nding of 3.9% patients <16 years in England and Wales). 5 There is also an older Swedish National Register that reported on patients aged 2 to 86 years, 6 and a later publication comparing their results with a Norwegian National Register of domiciliary liquid oxygen. 7 We now have good prevalence data estimating that 0.33 per 1000 children are oxygen dependent at home at some time. This is a signifi cant group of children (approximately 3.5 thousand) with a major disability. Most are <1 year (prevalence 1.08 per 1000), refl ecting the fact that by far, the commonest diagnostic indication is chronic neonatal lung disease. The number of children increases up to a maximum at 6 months of age because below that age, many of the children are still inpatients in neonatal units. Before collecting these data, it was not at all apparent that children with neurodisability were the second commonest diagnostic category receiving home oxygen, and this indication still needs clarifying. The BTS guidelines have suggested that quality of life rather than oxygen saturations should be the main consideration in this group. 2 We also have interesting data on regional differences in home oxygen use, with prevalence highest in the North East (0.48 per 1000) and North West (0.42 per 1000) of England and lowest in Yorkshire (0.25 per 1000). The reason for these differences is not yet apparent, and although it possibly relates to rates of preterm delivery, this warrants further study.
Unfortunately, both our datasets have problems. The provider's cross-sectional study is a comprehensive survey of children who were in possession of home oxygen, but we cannot be certain that they were using it at the time. In addition, the data recorded on the HOOFs were incomplete, with a minority containing diagnostic information and scant information provided on the use of oxygen accompanying home ventilation. This was partly because of poor completion of the HOOFs and partly because some companies did not record all the data. In contrast, the data from the CHORD database are of a high standard in detail but are signifi cantly incomplete in ascertainment. Differences in the proportions of HOOFs received from various regions compared with that expected from the provider's accurate regional data show how dependent CHORD was on willingness of prescribers to participate. It was not felt to be permissible to acquire the HOOF details routinely from the companies without parental consent. At the time of planning, the service we had indicated to the Department of Health that a clinical database was essential and should be a mandatory part of the ordering process, but this was also not possible. It was apparent how badly many of the HOOFs were completed (presumably mostly by doctors), which undoubtedly leads to delays in the companies providing the oxygen to the homes. The HOOF has since been modifi ed slightly and it is planned for there to be an electronic HOOF that may make it harder to provide incomplete information, although only if all fi elds are made mandatory.
In conclusion, we have surveyed the pattern of home oxygen prescribing across England and Wales and have estimated the prevalence in children by age and region. As expected, we found that the commonest indication was chronic neonatal lung disease, but surprisingly, the second commonest was neurodisability. This survey emphasises the need for a coordinated approach to oxygen prescribing in the UK and justifi es the recent publication of evidence-based guidelines for home oxygen prescribing. 
